Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthonius de Boer

Showing results (261-270 of 282) with videos related to

Pageof 29
Sort By:
Pharmacogenetics and Genomics|August 2, 2013
Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatmentLouise A Donnelly, Natalie R van Zuydam, Kaixin Zhou, et al.
Genes|September 16, 2020
Effect of <i>CYP3A4</i>*22 and <i>PPAR-α</i> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary InterventionThomas O Bergmeijer, Alfi Yasmina, Gerrit J A Vos, et al.
Pharmacogenomics|September 13, 2012
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costsTalitha I Verhoef, William K Redekop, Rianne Mf van Schie, et al.
Pharmacogenomics|August 28, 2012
Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original studyRianne M F van Schie, Nadia el Khedr, Talitha I Verhoef, et al.
American Heart Journal|June 23, 2014
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics studyThomas O Bergmeijer, Paul W A Janssen, Jurjan C Schipper, et al.
Pharmacogenomics|July 7, 2010
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivativesTalitha I Verhoef, William K Redekop, Josep Darba, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 20, 2017
Early life antibiotic use and the risk of asthma and asthma exacerbations in childrenFariba Ahmadizar, Susanne J H Vijverberg, Hubertus G M Arets, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumonTalitha I Verhoef, Georgia Ragia, Anthonius de Boer, et al.
Pharmacogenomics|April 6, 2016
A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol loweringMaarten Leusink, Anke H Maitland-van der Zee, Bo Ding, et al.
Pageof 29

Showing results (261-270 of 282) with videos related to

Sort By:
Pageof 29
Pharmacogenetics and Genomics|August 2, 2013
Robust association of the LPA locus with low-density lipoprotein cholesterol lowering response to statin treatment in a meta-analysis of 30 467 individuals from both randomized control trials and observational studies and association with coronary artery disease outcome during statin treatmentLouise A Donnelly, Natalie R van Zuydam, Kaixin Zhou, et al.
Genes|September 16, 2020
Effect of <i>CYP3A4</i>*22 and <i>PPAR-α</i> Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary InterventionThomas O Bergmeijer, Alfi Yasmina, Gerrit J A Vos, et al.
Pharmacogenomics|September 13, 2012
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costsTalitha I Verhoef, William K Redekop, Rianne Mf van Schie, et al.
Pharmacogenomics|August 28, 2012
Validation of the acenocoumarol EU-PACT algorithms: similar performance in the Rotterdam Study cohort as in the original studyRianne M F van Schie, Nadia el Khedr, Talitha I Verhoef, et al.
American Heart Journal|June 23, 2014
CYP2C19 genotype-guided antiplatelet therapy in ST-segment elevation myocardial infarction patients-Rationale and design of the Patient Outcome after primary PCI (POPular) Genetics studyThomas O Bergmeijer, Paul W A Janssen, Jurjan C Schipper, et al.
Pharmacogenomics|July 7, 2010
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivativesTalitha I Verhoef, William K Redekop, Josep Darba, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 20, 2017
Early life antibiotic use and the risk of asthma and asthma exacerbations in childrenFariba Ahmadizar, Susanne J H Vijverberg, Hubertus G M Arets, et al.
Pharmacoepidemiology and Drug Safety|April 3, 2016
Case-only designs for studying the association of antidepressants and hip or femur fractureMark C H de Groot, Gianmario Candore, Md Jamal Uddin, et al.
The New England Journal of Medicine|November 21, 2013
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumonTalitha I Verhoef, Georgia Ragia, Anthonius de Boer, et al.
Pharmacogenomics|April 6, 2016
A genetic risk score is associated with statin-induced low-density lipoprotein cholesterol loweringMaarten Leusink, Anke H Maitland-van der Zee, Bo Ding, et al.
Pageof 29